Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
3,912,182
-
Share change
-
+300
-
Total reported value
-
$162,469,912
-
Price per share
-
$41.54
-
Number of holders
-
25
-
Value change
-
+$12,000
-
Number of buys
-
1
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q4 2013
As of 31 Dec 2013,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,912,182 shares.
The largest 10 holders included
VHCP Management, LLC, PRUDENTIAL PLC, FARALLON CAPITAL MANAGEMENT LLC, FMR LLC, Redmile Group, LLC, ORBIMED ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Pier Capital, LLC, and ABINGWORTH LLP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.